Edition:
United States

Chemed Corp (CHE.N)

CHE.N on New York Stock Exchange

187.96USD
4:02pm EDT
Change (% chg)

$-5.50 (-2.84%)
Prev Close
$193.46
Open
$193.63
Day's High
$193.75
Day's Low
$186.55
Volume
34,712
Avg. Vol
30,805
52-wk High
$216.01
52-wk Low
$132.92

Chart for

About

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians,... (more)

Overall

Beta: 1.13
Market Cap(Mil.): $3,093.79
Shares Outstanding(Mil.): 15.99
Dividend: 0.28
Yield (%): 0.58

Financials

  Industry Sector
P/E (TTM): -- 29.78 16.18
EPS (TTM): -- -- --
ROI: -- 6.59 14.60
ROE: -- 10.42 13.87

BRIEF-Chemed Corp increases quarterly dividend 7.7 pct

* Says declared quarterly cash dividend of 28-cents per share Source text for Eikon: Further company coverage:

Aug 04 2017

BRIEF-Chemed Corp qtrly ‍adjusted diluted eps $2.15​

* Chemed Corp qtrly ‍net patient revenue of $285 million, an increase of 2.1%​

Jul 25 2017

BRIEF-Chemed reports Q1 GAAP earnings per share $1.78

* Says revenue growth for vitas in 2017, prior to medicare cap, is estimated to be in range of 4% to 5%

Apr 26 2017

BRIEF-Chemed Corp CEO Kevin Mcnamara's 2016 compensation $6.5 mln

* Chemed corp - ceo kevin mcnamara's total compensation for 2016 was $6.5 million versus $7.4 million in 2015 - sec filing Source text for Eikon: Further company coverage:

Mar 31 2017

Earnings vs. Estimates